Cresset Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Cresset Asset Management's RGEN Position: Q1 2025 in Review
Cresset Asset Management sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,432 shares — an estimated $206K sold.
Cresset Asset Management first reported a position in RGEN in Q4 2018 and held it in 10 quarters. The position peaked at $389K in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Cresset Asset Management reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Cresset Asset Management sold 1,432 Repligen shares in Q1 2025, an estimated $206K.
- Cresset Asset Management first reported a position in Repligen in Q4 2018 and held it in 10 quarters.
- Cresset Asset Management's Repligen position peaked at $389K in Q3 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Cresset Asset Management's 13F filing for Q1 2025, filed 13 May 2025.